Phase I and Pharmacokinetic Study of Cetuximab and Irinotecan in Children With Refractory Solid Tumors: A Study of the Pediatric Oncology Experimental Therapeutic Investigators' Consortium

PURPOSE: To determine the dose of cetuximab that can be safely combined with irinotecan for treatment of pediatric and adolescent patients with refractory solid tumors. PATIENTS AND METHODS: This open-label, phase I study enrolled patients ages 1 to 18 years with advanced refractory solid tumors, in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Oncol
Main Authors: Trippett, Tanya M., Herzog, Cynthia, Whitlock, James A., Wolff, Johannes, Kuttesch, John, Bagatell, Rochelle, Hunger, Stephen P., Boklan, Jessica, Smith, Amy A., Arceci, Robert J., Katzenstein, Howard M., Harbison, Christopher, Zhou, Xiaofei, Lu, Haolan, Langer, Christiane, Weber, Martin, Gore, Lia
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2009
Fag:
ORIGINAL REPORTS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5321093/
https://ncbi.nlm.nih.gov/pubmed/19770383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.20.8975
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker